Tumor marker NSE-neuron-specific enolase
610 UAH
NSE (neuron-specific enolase) is a protein used as a laboratory marker in the screening and monitoring of certain neuroendocrine tumors, including small cell lung cancer. The test is performed on a blood sample. The result is evaluated together with symptoms, imaging studies, and other laboratory parameters. This test alone does not confirm or rule out cancer.
NSE, or neuron-specific enolase, is one of the key tumor markers used in the diagnosis of various types of cancer. This protein, which is produced by neurons and neuroendocrine cells, is often found in elevated concentrations in the blood of patients with tumors, especially those with brain metastases. The detection of elevated levels of NSE can serve as an important indicator of tumor progression and treatment effectiveness.
Tumor marker diagnostics
Tumor marker diagnostics is an important step in the detection and monitoring of cancer. Tumor markers, such as NSE, CA-125, PSA, and others, help doctors in the early detection of tumors, assessing their size and growth dynamics. They are also used to monitor the effectiveness of treatment and detect relapses. Accurate and timely diagnosis using tumor markers allows for early treatment and improves the prognosis for cancer patients.
| Execution time | 1 day |
|---|---|
| Type of biomaterial | Venous blood |
Useful tests
